Ashton Tweed Connection Vol. 4 No. 5

ASHTON TWEED CONNECTION

VOL. 4 NO. 5

Featuring CEO Interview with James Caruso, President & CEO, Cellectar Biosciences

Your Issue of Ashton Tweed Connection Vol. 4 No. 5 is Here!

Our Site

Contact us

Vol. 4

No. 5

Ashton Tweed can meet your specialized retained search & interim talent needs in the life sciences industry.

CEO Leadership Series: James Caruso, President & CEO, Cellectar Biosciences

In his 27 years as a biotech and pharmaceutical professional, James Caruso has held key executive positions at organizations of all sizes, from Big Pharma to small specialty companies to a startup. One constant throughout his career...

Read More

Blog: 5 Reasons it's More Than Just a Thank-You Email

Blog: 5 Reasons it's More Than a Thank-You Email

That's right, not a text, but a thank you email! Whether it's after an interview, a networking event, or a business lunch, it all matters! Most of us have been encouraged to send thank you emails promptly after professional interactions...

Blog: Top 5 Podcasts for Life Science Execs

Have some free time while traveling, commuting, or working out? Put it to good use! Podcasts are a great way to make the most of your down time by getting your gears turning and keeping you up-to-date with the latest industry news and...

Don't miss out on top hiring news!

Ashton Tweed's Weekly Digest email covers hiring, firing, & retiring news in the life sciences. Also, check out our:

Featured Candidates

Upcoming Events

Recent Editions

Subscribe Now!

Life Sciences Professionals Name Top 30 Ideal Employers

According to the 2017 Life Sciences Ideal Employer Report, the top three most important attributes are the opportunity to do interesting and meaningful work, a competitive salary and a good reputation. BioSpace surveyed more than 2,400...

FDA’s Generic Drugs Office Passes Last Year’s Record for ANDAs Received

FDA Passes Last Year's Record for ANDAs Received

Two-thirds of the way through fiscal year 2017, the FDA has received at least 877 ANDAs, passing 2016's total of 852 and beating 2015 by more than 330 applications. So far, the agency has totaled 477 approvals for 2017, 119 of ...

EpiPen alternative Symjepi gets FDA OK

The FDA has approved a new allergic reaction medication that could provide an alternative to Mylan's EpiPen. Adamis Pharmaceuticals' Symjepi comes as two pre-filled syringes of epinepherine and is indicated for...

J&J, Pfizer, Merck sit atop Fortune's 500 for pharma

J&J, Pfizer and Merck top Fortune's 500 for the pharma industry, but large drug wholesalers and pharmacy benefit managers beat them easily. In 2017's Fortune 500 list, which identifies companies that have generated...

Featured Event: MedCity CONVERGE

When: July 31-August 1, 2017 Where: Philadelphia, PA This event is a two-day executive summit that gathers all sectors of healthcare to provide the most accurate picture of the future of healthcare innovation...

Read More

Supreme Court ruling gives biosimilars a boost

Biosimilar makers could get drugs to market more quickly following a recent ruling from the Supreme Court. In a unanimous opinion, the Supreme Court ruled that biosimilar drug developers won't have to wait for FDA approval...

Supreme Court ruling gives biosimilar makers a boost

Launching the Biden Cancer Initiative

Vice President Joe Biden and Dr. Jill Biden launched the Biden Cancer Initiative, their new venture to accelerate progress in cancer prevention, detection, diagnosis, research and care, and to reduce...

About Ashton Tweed, Ltd.

At the very core of Ashton Tweed's talent-acquisition and talent-placement business is a robust professional force of highly experienced life sciences industry experts. These uniquely talented professionals are deployed throughout Ashton Tweed’s diverse range of service offerings to solve our clients’ human capital and management needs.